Press "Enter" to skip to content

July 2022 Data Refresh on LTCH Compare & IRF Compare

Share this:

Data has been updated on both Long-term Care Hospital (LTCH) Compare and Inpatient Rehabilitation Facility (IRF) Compare Websites as part of the July 2022 quarterly update.

LTCH COMPARE

The LTCH Compare 2022 July refresh included updated quality measure results for over 420 long-term care hospitals that report data to the Centers for Medicare & Medicaid Services (CMS), as part of its Long-term Care Hospital Quality Reporting Program (QRP).

The data are based on quality assessment data submitted by LTCHs to Centers for Medicare & Medicaid Services (CMS) from Quarter 4, 2020 through Quarter 3, 2021, and for the LTCH Change in Mobility measure, Quarter 4, 2019 and Quarter 3, 2020 through Quarter 3, 2021. Additionally, the Centers for Disease Control and Prevention (CDC) measures reflect data from Quarter 3, 2020 through Quarter 2, 2021 for the Clostridium Difficile Infection (CDI), Catheter-Associated Urinary Tract Infections (CAUTI), and Central Line-Associated Bloodstream Infections (CLABSI) measures, as well as Quarter 4, 2018 through Quarter 1, 2019 for the Healthcare Personnel (HCP) Influenza measure. This refresh also resumes the reporting of all claims-based measures. Due to the COVID-19 reporting exceptions, the claims-based measures have been calculated excluding Q1 and Q2 2020 data from measure calculations. The data for the claims-based measures will display data from Quarter 3, 2019 through Quarter 4, 2019 and Quarter 3, 2020 through Quarter 2, 2021 for this refresh.

Measures reported on LTCH Compare include:

Complications (Healthcare-acquired conditions): (Q4 2020_Q3 2021)

  • Percentage of patients with pressure ulcers/pressure injuries that are new or worsened
  • Percentage of LTCH patients who experience one or more falls with major injury during their LTCH stay

Result of Care (Q3 2019_Q4 2019) and (Q4 2020_Q3 2021)

  • Change in ability to move around for patients admitted on a ventilator
  • Percentage of patients that were successfully weaned from the ventilator during their LTCH stay

Effective care: (Q4 2020_Q3 2021)

  • Percentage of patients whose activities of daily living and thinking skills were assessed and related goals were included in their treatment plan
  • Percentage of LTCH patients whose functional abilities were assessed and functional goals were included in their treatment plan
  • Percentage of patients on ventilators assessed for readiness to begin breathing trials without a ventilator within the first 2 days of their LTCH stay and Percentage of patients on ventilators who appropriately received breathing trials within the first 2 days of their LTCH stay.

Medication Reconciliation (Q4 2020_Q3 2021)

  • Percentage of patients whose medications were reviewed and who received follow-up care when medication issues were identified

Infections (Healthcare-associated infections): (Q3 2020_Q2 2021)

  • Catheter-associated urinary tract infections (CAUTI)
  • Central line-associated bloodstream infections (CLABSI)
  • Clostridium difficile infection (CDI)

Prevention: (Q4 2018_Q1 2019)

  • Influenza vaccination coverage among healthcare personnel

Readmissions: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Rate of potentially preventable hospital readmissions 30 days after discharge from an LTCH

Successful return to home and community: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Rate of successful return to home or community from an LTCH

Payment & value of care: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Medicare Spending Per Beneficiary (MSPB) for patients in LTCHs

IRF COMPARE

The IRF Compare refresh includes updated quality measure results for over 1,100 inpatient rehabilitation facilities that report data to the Centers for Medicare & Medicaid Services (CMS), as part of its Inpatient Rehabilitation Facility Quality Reporting Program (QRP).

The data are based on quality assessment data submitted by IRFs to Centers for Medicare & Medicaid Services (CMS) from Quarter 4, 2020 through Quarter 3, 2021. Additionally, the Centers for Disease Control and Prevention (CDC) measures reflect data from Quarter 3, 2020 through Quarter 2, 2021 for the Clostridium Difficile Infection (CDI) and Catheter-Associated Urinary Tract Infections (CAUTI) measures, as well as Quarter 4, 2018 through Quarter 1, 2019 for the Healthcare Personnel (HCP) Influenza measure. This refresh also resumes the reporting of all claims-based measures. Due to the COVID-19 reporting exceptions, the claims-based measures have been calculated excluding Q1 and Q2 2020 data. The data for the claims-based measures will display data from Quarter 3, 2019 through Quarter 4, 2019 and Quarter 3, 2020 through Quarter 2, 2021 for this refresh.

Measures reported on IRF Compare include:

Complications (Healthcare-acquired conditions): (Q4 2020_Q3 2021)

  • Percentage of patients with pressure ulcers that are new or worsened
  • Percentage of IRF patients who experience one or more falls with major injury during their IRF stay

Results of Care (Q4 2020_Q3 2021)

  • Change in patients’ ability to care for themselves
  • Change in patients’ ability to move around

Effective care: (Q4 2020_Q3 2021)

  • Percentage of IRF patients whose functional abilities were assessed and functional goals were included in their treatment plan
  • Percentage of patients who are at or above an expected ability to care for themselves at discharge
  • Percentage of patients who are at or above an expected ability to move around at discharge

Medication Reconciliation (Q3 2020_Q2 2021)

  • Percentage of patients whose medications were reviewed and who received follow-up care when medication issues were identified

Infections (Healthcare-associated infections): (Q3 2020_Q2 2021)

  • Catheter-associated urinary tract infections (CAUTI)
  • Clostridium difficile infection (CDI)

Prevention: (Q4 2018_Q3 2019)

  • Influenza vaccination coverage among healthcare personnel

Readmissions: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Rate of potentially preventable hospital readmissions 30 days after discharge from an IRF
  • Rate of potentially preventable hospital readmissions during the IRF stay

Successful return to home and community: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Rate of successful return to home or community from an IRF

Payment & value of care: (Q3 2019_Q4 2019 and Q3 2020_Q2 2021)

  • Medicare Spending Per Beneficiary (MSPB) for patients in IRFs

Read more:

Share this: